← All organizations
Highest phase reached
Phase 4
First clinical trial
Sep 1, 1989Last known activity
Aug 29, 2025
Timeline
1810s
- Feb 25, 1811
Mclean Hospital— Founded
Drugs by trial phase (76 distinct, 118 trials)
Phase 4 (21 own, 0 via acquisition)
Phase 3 (6 own, 0 via acquisition)
Phase 2 (25 own, 0 via acquisition)
Phase 1 (12 own, 0 via acquisition)
Other trials (12 own, 0 via acquisition)
Indications
Studied for
- Alcohol Abstinence
- Alcohol Drinking
- Alcoholism
- Alzheimer Disease
- Anxiety Disorders
- Autism Spectrum Disorder
- Autistic Disorder
- Behavioral Symptoms
- Binge-Eating Disorder
- Bipolar Disorder
- Borderline Personality Disorder
- Brain Injuries
- Brain Injuries, Traumatic
- Bulimia
- Cardiovascular Diseases
- Child Development Disorders, Pervasive
- Chronic Pain
- Cocaine-Related Disorders
- Cognitive Dysfunction
- Compulsive Personality Disorder
- Dementia
- Depression
- Depressive Disorder
- Depressive Disorder, Treatment-Resistant
- Disease
- Feeding and Eating Disorders
- Heroin Dependence
- Irritable Bowel Syndrome
- Major Depressive Disorder
- Marijuana Abuse
- Mental Disorders
- Mood Disorders
- Mycoses
- Neurobehavioral Manifestations
- Obsessive-Compulsive Disorder
- Personality Disorders
- Phobia, Social
- Psychomotor Agitation
- Psychotic Disorders
- Recurrence
- Schizophrenia
- Stress Disorders, Post-Traumatic
- Substance-Related Disorders
- Syndrome
- Tobacco Use Disorder
Recent trials (50)
- NCT06943404CollaboratorPhase 2Aug 29, 2025
- NCT06786637Lead sponsorPhase 2Jun 30, 2025
- NCT06786637Sponsor investigatorPhase 2Jun 30, 2025
- NCT06786637OfficialPhase 2Jun 30, 2025
- NCT06876129Sponsor investigatorPhase 1Apr 1, 2025
- NCT06876129OfficialPhase 1Apr 1, 2025
- NCT06876129Lead sponsorPhase 1Apr 1, 2025
- NCT06636786CollaboratorPhase 2Oct 31, 2024
- NCT06477406OfficialPhase 2Aug 31, 2024
- NCT06477406Sponsor investigatorPhase 2Aug 31, 2024
- NCT06477406Lead sponsorPhase 2Aug 31, 2024
- NCT06422208Lead sponsorPhase 1Aug 7, 2024
- NCT06422208Sponsor investigatorPhase 1Aug 7, 2024
- NCT06191965OfficialPhase 2/Phase 3Jun 1, 2024
- NCT06191965Lead sponsorPhase 2/Phase 3Jun 1, 2024
Details
- Founded
- Belmont, Massachusetts, US Feb 25, 1811
- Last known activity
- Aug 29, 2025